Aquatic Animal Health Research Site Logo
ARS Home About Us Helptop nav spacerContact Us En Espanoltop nav spacer
Printable VersionPrintable Version     E-mail this pageE-mail this page
Agricultural Research Service United States Department of Agriculture
Search
  Advanced Search
 
Programs and Projects
Subjects of Investigation
 

Research Project: VACCINOLOGY AND IMMUNITY OF AQUATIC ANIMALS

Location: Aquatic Animal Health Research

Title: Bath immersion, booster vaccination strategy holds potential for protecting juvenile tilapia against Streptococcus iniae

Authors

Submitted to: Global Aquaculture Advocate
Publication Type: Peer Reviewed Journal
Publication Acceptance Date: March 18, 2008
Publication Date: May 1, 2008
Citation: Klesius, P.H., Shoemaker, C.A., Evans, J.J. 2008. Bath immersion, booster vaccination strategy holds potential for protecting juvenile tilapia against Streptococcus iniae. Global Aquaculture Advocate. 11(3): 49-50.

Interpretive Summary: Streptococcus iniae is a significant bacterial pathogen that causes hemorrhagic septicemia and meningoencephalitis in tilapia, hybrid striped bass, rainbow trout, olive flounder, yellowtail, barramundi and other species of cultured and wild fish worldwide. In tilapia production, vaccination of fry against the bacteria is essential to reduce economic losses. The goal of vaccination is to elicit a strong immune responce to the administered antigen that is capable of prividing long-term protection against infection. However, information on the efficacy of modifiied S. iniae vaccines in newly hatched tilapia fry is limited.

Technical Abstract: Streptococcus iniae is a significant bacterial pathogen that causes hemorrhagic septicemia and meningoencephalitis in tilapia, hybrid striped bass, rainbow trout, olive flounder, yellowtail, barramundi and other species of cultured and wild fish worldwide. In tilapia production, vaccination of fry against the bacteria is essential to reduce economic losses. The goal of vaccination is to elicit a strong immune responce to the administered antigen that is capable of prividing long-term protection against infection. However, information on the efficacy of modifiied S. iniae vaccines in newly hatched tilapia fry is limited.

   

 
Project Team
Klesius, Phillip
Xu, Dehai
Evans, Joyce
Shoemaker, Craig
Lafrentz, Benjamin
Pridgeon, Yuping - Julia
 
Publications
   Publications
 
Related National Programs
  Aquaculture (106)
 
 
Last Modified: 05/25/2013
ARS Home | USDA.gov | Site Map | Policies and Links 
FOIA | Accessibility Statement | Privacy Policy | Nondiscrimination Statement | Information Quality | USA.gov | White House